JUN 21, 2018
Academy Again Makes the Case for Access to Office-Use Compounded Treatments
As the Food and Drug Administration revisits availability of office-use treatments, we're reminding officials that they must not jeopardize our ability to treat blinding ailments like endophthalmitis